IOR Institute of Oncology Research

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers, Antibodies, Stem Cells, Drug Delivery, Drug Devices

Therapeutic Areas of Expertise: Oncology

Center/Program Highlights:

The Institute of Oncology Research was established in 2003 as the Laboratory of Experimental Oncology and as part of the Research Division of the Oncology Institute of Southern Switzerland (IOSI).
In September 2011 the institute became independent and is now managed administratively through the Foundation for the Institute of Oncology Research (President, Prof. Franco Cavalli).
As of January 2017, the Institute of Oncology Research was integrated as an academic institute within the Faculty of Biomedical Sciences of the University of Lugano (USI).
Research activities are divided into two main programs, each including various research teams. The first program is dedicated to solid tumors, such as prostate cancer, and the second program deals with hematological diseases and lymphomas.

Sources of Funding: Federal/State, Philanthropy, Industry Partnerships, University


Institutional Affiliation(s): Faculty of Biomedical Sciences, USI

via Vela 6
TI, 6500

Center/Program Start Date: 2003

Number of Employees: 60